Navin Fluorine extends Solstice supply deal to 11 years, worth $590m

Navin Fluorine International Limited extended its hydrofluoroolefin (HFO) supply contract with Solstice Advanced Materials US, Inc. to 11 years, lifting total potential value to about $590 million after a four-year extension worth about $180 million. Navin Fluorine also expects its up-to-15,000 MTPA R32-equivalent hydrofluorocarbon (HFC) project, with Rs. 236.5 crore of capex, to be commissioned shortly.

What did Navin Fluorine agree with Solstice?

Navin Fluorine extended its HFO supply agreement with Solstice by four years beyond the original seven-year period, taking the total contract term to 11 years. The extension adds about $180 million of potential revenue, and the total potential contract value is now about $590 million over the 11-year period.

The presentation describes the $590 million as potential revenue rather than reported sales. It does not disclose annual contract volumes, a pricing mechanism, the contract start or end date, purchase obligations, or the portion of the potential value already supplied. Therefore, the presentation does not provide a basis for calculating annual revenue from the Solstice agreement.

The agreement is disclosed within Navin Fluorine's High Performance Products, or HPP, vertical. HPP revenue rose 49% year on year to Rs. 604 crore in Q2 FY27 from Rs. 404 crore in Q2 FY26, with management attributing the increase to higher volume and improved realisations. Management also said the HFC pricing environment remained firm, with quarter-on-quarter improvement in realisation.

How large is Navin Fluorine's HFC capacity project?

Navin Fluorine is adding HFC capacity equivalent to up to 15,000 metric tonnes per annum (MTPA) of R32 through a Rs. 236.5 crore project that is expected to be commissioned shortly. The project is to be funded through internal accruals and has annual peak revenue potential of about Rs. 600 crore to Rs. 825 crore.

The company says the project responds to a constructive global demand-supply environment, a transition to lower global-warming-potential gases, and increasing refrigeration and air-conditioning demand in India and export markets. The capacity is described as R32-equivalent, and the presentation does not state that the entire 15,000 MTPA capacity is allocated to the 11-year Solstice agreement.

The Rs. 600 crore to Rs. 825 crore figure is identified as annual peak revenue potential, while the commissioning timeline is described only as shortly. Navin Fluorine does not disclose the utilisation ramp-up period, expected margin, annual production volume beyond the up-to-15,000 MTPA specification, or the timing for attaining peak revenue.

How did Navin Fluorine's HPP business perform in Q2 FY27?

Navin Fluorine's HPP revenue increased by Rs. 200 crore to Rs. 604 crore in Q2 FY27 from Rs. 404 crore in Q2 FY26, making it the largest of its three disclosed operating verticals. Specialty Chemicals reported Rs. 348 crore and contract development and manufacturing organisation (CDMO) revenue was Rs. 239 crore in Q2 FY27.

HPP generated the highest quarterly revenue, but CDMO recorded the fastest percentage growth at 78%, followed by Specialty Chemicals at 58%. The comparison shows that the Solstice contract extension and R32-equivalent expansion are being disclosed as HPP revenue rises from a larger base, although Navin Fluorine provides no HPP-level profit or order-book figure.

At the consolidated level, revenue from operations rose 57% year on year to Rs. 1,190.74 crore in Q2 FY27 from Rs. 758.42 crore in Q2 FY26. It also increased 14% from Rs. 1,045.08 crore in Q1 FY27. Operating earnings before interest, tax, depreciation and amortisation (EBITDA) increased 66% year on year to Rs. 407.45 crore, while operating EBITDA margin rose 176 basis points to 34.22%.

Which other Navin Fluorine projects have stated milestones?

Navin Fluorine has set a Q3 FY27 commissioning target for its Rs. 120 crore Chemours project and an end-Q4 FY27 operationalisation target for the Rs. 125 crore Phase II cGMP4 project. The Chemours project will provide initial commercial capacity for an innovative liquid-cooling product, with 35% of capex funded by the customer and the remaining amount funded through internal accruals.

Specialty Chemicals stated that purchase orders are in place for Chemours-project deliveries during Q4 FY27. Its revenue grew 58% to Rs. 348 crore in Q2 FY27 from Rs. 220 crore a year earlier. The business also commissioned de-bottlenecked multipurpose plant capacity at Dahej in September 2026 and cited strong order visibility in the second half of FY27 and beyond.

The Rs. 125 crore Phase II cGMP4 project is linked to increasing demand for an existing molecule of a European CDMO major and a larger supply-chain footprint. Navin Fluorine states an asset-turnover expectation of about three times for the project. CDMO revenue rose by Rs. 105 crore to Rs. 239 crore in Q2 FY27 from Rs. 134 crore in Q2 FY26.

Advanced Materials adoption capacities require Rs. 90 crore of capex and are scheduled for completion by Q2 FY28. A separate Rs. 15.73 crore hybrid renewable-power project covers 14.9 megawatts of capacity. Management says that project is intended to take renewable sources above 60% of energy needs, but does not provide a commissioning date.

Conclusion

The 11-year Solstice agreement gives Navin Fluorine disclosed HFO supply revenue potential of about $590 million, while its Rs. 236.5 crore HFC project has annual peak revenue potential of about Rs. 600 crore to Rs. 825 crore. These plans sit alongside Q2 FY27 HPP revenue of Rs. 604 crore, up 49% year on year, and consolidated operating EBITDA of Rs. 407.45 crore, up 66%.

The next disclosed milestones are HFC commissioning shortly, Chemours-project completion by Q3 FY27 with deliveries planned during Q4 FY27, and Phase II cGMP4 operationalisation by the end of Q4 FY27. Further disclosures on HFC utilisation, Solstice volumes and pricing, and the timing of peak revenue from the added capacity would clarify execution against the stated plans.